This Is Huge News for Novo Nordisk (Hint: It Doesn't Involve Ozempic)
Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...
Novo Nordisk fights ‘copycat’ versions of Ozempic and Wegovy amid high demand for weight-loss drugs
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
KSL19h
Weight loss drugs didn't curb health costs within 2 years, data show
The full-year cost of care for U.S. patients with obesity, two years after starting on Novo Nordisk's Wegovy or similar GLP-1 ...
Daily27m
West Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies
Bengaluru: West Pharmaceutical Services raised its annual profit outlook on Thursday after exceeding Wall Street's ...
India Education Diary21h
UC Davis and BioInnovation Institute Join Forces to Advance Global Protein Nutrition
The University of California, Davis today announced an expanded collaboration with the BioInnovation Institute (BII) to ...
Patients Taking Ozempic Are Up to 70 Percent Less Likely to Develop Alzheimer’s, Research Finds
The active ingredient in Ozempic and Wegovy has once again proven to have health effects outside of weight loss in a huge ...
Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t
The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
Benzinga Bulls And Bears: Nvidia, Tesla, MicroStrategy, Plug Power — And Crypto Traders Anticipate Dogecoin Topping 50 Cents
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top ...
The Jerusalem Post Blogs6h
Israel News
The 47-year-old reservist from Kibbutz Mevo Hama, left behind his wife Dafna, daughters, Mika and Gaya, and son Amit, according to Ynet. Information ...